ODAC approves indication for sunitinib in treatment of PNET
Links shared publicly online about this topic.
- 370total visits
ODAC approves indication for sunitinib in treatment of PNET
The FDA’s Oncologic Drugs Advisory committee voted 8-2 today in support of the use of Pfizer’s sunitinib in the treatment of unresectable
View full resource at endocrinetoday.com
Tags: Bone Cancer, Ewing Family of Tumors, Drug, Oncology
Most Recently Shared on April 12, 2011 at 9:14 pm By:
#ODAC approves indication for #sunitinib in treatment of PNET http://bit.ly/i9bfOG
ODAC approves indication for sunitinib in treatment of PNET | HemOncToday
hemonctoday.com — “The FDA’s Oncologic Drugs Advisory committee voted 8-2 today in support of the use of Pfizer’s sunitinib in the treatment of unrese” View full resource at hemonctoday.com
Most Recently Shared on April 12, 2011 at 8:54 pm By:
JanCerny, MD, PhD Internist, Oncologist, Hematologist, Physician, Doctor, and PhD
RT @hemonctoday: #ODAC approves indication for #sunitinib in treatment of PNET http://bit.ly/gl1E7R
Advertisement
